Skip Navigation


JAC Advance Access originally published online on August 10, 2006
Journal of Antimicrobial Chemotherapy 2006 58(4):748-751; doi:10.1093/jac/dkl326
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
58/4/748    most recent
dkl326v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Houdouin, V.
Right arrow Articles by Bingen, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Houdouin, V.
Right arrow Articles by Bingen, E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Phylogenetic background and carriage of pathogenicity island-like domains in relation to antibiotic resistance profiles among Escherichia coli urosepsis isolates

Véronique Houdouin1, Stéphane Bonacorsi1, Philippe Bidet1, Martine Bingen-Bidois2, Dominique Barraud2 and Edouard Bingen1,*

1 Laboratoire d'études de génétique bactérienne dans les infections de l'enfant (EA3105), Université Denis Diderot-Paris 7 AP-HP, Hôpital Robert Debré, Service de Microbiologie, 75019 Paris, France 2 Laboratoire de Bactériologie Centre Hospitalier de Gonesse, Gonesse, France

Received 22 March 2006; returned 5 July 2006; revised 6 July 2006; accepted 14 July 2006

*Correspondence address. Service de Microbiologie, Hôpital Robert Debré, 48 Bd Sérurier, 75395 Paris cedex 19, France. Tel: +33-1-40-03-23-40; Fax: +33-1-40-03-24-50; E-mail: edouard.bingen{at}rdb.ap-hop-paris.fr

We studied 100 well-characterized E. coli blood isolates from patients with urosepsis for their susceptibility to nalidixic acid, ampicillin and trimethoprim–sulfamethoxazole, according to prevalence of virulence factors, phylogenetic groups and subgroups, PAI IIJ96-like domains (determined by physical linkage of cnf1, hly and hra) and PAI ICFT073-like domains (determined by physical linkage of papGII to the hly locus). Nalidixic acid resistance was associated with a lower prevalence of sfa/foc, K1 antigen, pathogenicity island IIJ96-like domains, subgroup B2/I and a shift towards group A.

Keywords: virulence factors , ribotyping , quinolones , PCR


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 MicrobiologyHome page
C. Bronowski, S. L. Smith, K. Yokota, J. E. Corkill, H. M. Martin, B. J. Campbell, J. M. Rhodes, C. A. Hart, and C. Winstanley
A subset of mucosa-associated Escherichia coli isolates from patients with colon cancer, but not Crohn's disease, share pathogenicity islands with urinary pathogenic E. coli
Microbiology, February 1, 2008; 154(2): 571 - 583.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Microbiol.Home page
G. Piatti, A. Mannini, M. Balistreri, and A. M. Schito
Virulence Factors in Urinary Escherichia coli Strains: Phylogenetic Background and Quinolone and Fluoroquinolone Resistance
J. Clin. Microbiol., February 1, 2008; 46(2): 480 - 487.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.